	Diagnostic efficacy of blood biomarkers for differentiating early-stage pancreatic cancer from chronic pancreatitis: A systematic review and network meta-analysis. Transl Oncol Wu D, Du ZK, Wang YC, Zheng YZ, Qi HM, Zhu YR, Cao Y, Wang L, Zou WB, Liao Z. PMID: 41547146 [PubMed - as supplied by publisher]
	Risk score development for pancreatic cancer in Chinese men: A population-based cohort study. Cancer Epidemiol Cai J, Chen H, Zhang Y, Lu B, Lu M, Luo C, You L, Dai M. PMID: 41547117 [PubMed - as supplied by publisher]
	GDF15 in the tumor microenvironment: A central mediator of cancer immunometabolism and therapeutic resistance. Cytokine Growth Factor Rev Lu L, Johnson CH, Khan SA, Irwin ML. PMID: 41546893 [PubMed - as supplied by publisher]
	Post-surgery weight changes in pancreatic cancer: a prospective study on factors and survival impact. World J Surg Oncol Cui L, Zhang L, Yu H, Sun Q, Jiang K, Wei J, Fang X. PMID: 41545995 [PubMed - as supplied by publisher]
	Protein palmitoylation and immune regulation in pancreatic ductal adenocarcinoma: Integrating insights from cross-cancer studies. Biochim Biophys Acta Rev Cancer Cui X, Li C, Zhong X, Sun A, Lan Y, Wang Z. PMID: 41544825 [PubMed - as supplied by publisher]
	Gender Differences in Prognosis of Pancreatic Neuroendocrine Tumors: A Retrospective Cohort Study Based on the SEER Database. Cancer Control Li Y, Zhou S, Qiao Q, Ji K, Li Q, Qiao Z, Zhang P. PMID: 41544666 [PubMed - indexed for MEDLINE]
	ZG16B: A key regulator of tumor progression and immune microenvironment modulation in cancer (Review). Int J Mol Med Chen XM, Liang YB, Zuo JX, Yang ZS, Zhang LY, Zhang XY, Wan P, Ke Y. PMID: 41543187 [PubMed - indexed for MEDLINE]
	Unveiling sex differences in pancreatic ductal adenocarcinoma: Current evidence and future directions (Review) . Int J Oncol Rauschenberg S, Orgler-Gasche E, Karakas Zeybek D, Regel I, Löhr JM, Öhlund D, Günther M, Aguilera Munoz L. PMID: 41543183 [PubMed - indexed for MEDLINE]
	Inferring Clinically Relevant Molecular Subtypes of Pancreatic Cancer from Routine Histopathology Using Deep Learning. medRxiv Akbar AR, Levya A, Esnakula A, Hasanov E, Noonan A, Manne U, Sahai V, Meng L, Tsai S, Parwani A, Chen W, Manne A, Khan Niazi MK. PMID: 41542662 [PubMed]
	Circulating tumour DNA (ctDNA) as a predictor of progression-free and overall survival in non-resectable pancreatic cancer: a systematic review and meta-analysis. J Liq Biopsy Steiniche MM, Callesen LB, Vlk EH, Ventzel L, Timm S, Andersen RF, Lindgaard SC, Hansen TF, Ladekarl M, Spindler KG. PMID: 41541743 [PubMed]
	A scoping review of breakthrough cancer pain: Multidimensional patient needs and influencing factors. Asia Pac J Oncol Nurs Li Q, Sheng Y, Liu X, Li J, Zhu L, Yang Y, Hu L. PMID: 41541009 [PubMed]
	Scaffold optimization trends in matrix metalloproteinase inhibitors for selective pancreatic cancer Therapy-A review. Eur J Med Chem Kolli K, Kumar D. PMID: 41539274 [PubMed - as supplied by publisher]
	Impact of pancreatic transection level on survival outcomes and glycemic control following distal pancreatectomy for pancreatic tail cancer: A multicenter cohort study. Eur J Surg Oncol Lee JS, Cassese G, Yoon YS, Han HS, Lee B, Park Y, Jang JY, Kwon W, Lim CS. PMID: 41539036 [PubMed - as supplied by publisher]
	Clinical and Molecular Characteristics of Patients With Young-Onset and Average-Onset Pancreatic Adenocarcinoma. JCO Precis Oncol Gamboa AC, Lewis KA, Prakash LR, Li Z, Qiao W, Zhao D, Hurd MW, Yousef M, Ikoma N, Kim MP, Lee JE, Maxwell JE, Tzeng CD, Katz MHG, Snyder RA. PMID: 41538760 [PubMed - indexed for MEDLINE]
	Contemporary Multidisciplinary Treatment of Borderline-Resectable and Locally Advanced Pancreatic Adenocarcinoma. Am Soc Clin Oncol Educ Book Joung RH, Snyder RA. PMID: 41538745 [PubMed - indexed for MEDLINE]
	A commentary on "Multimodal radiopathomics approach for predictions of prognosis and immunotherapy response in patients with gastric cancer: a multicohort retrospective study". Int J Surg Mohetaer A, Adili D. PMID: 41537318 [PubMed - as supplied by publisher]
	The expression of genes KRAS, DPM1, ACRV1, and MBD3L2 in the saliva as potential tumor markers in the detection of pancreatic cancer. Pol Przegl Chir Ciosek J, Dranka-Bojarowska D, Lewi, Lampe P. PMID: 41537300 [PubMed - indexed for MEDLINE]
	The Predictive Performance of Tumor Morphological Features on MRI Combined With Serum CA19-9 for the Efficacy of TACE Treatment in Patients With Primary Liver Cancer. Ann Ital Chir Shen M, Zhang W, Shen H, Wang B. PMID: 41537205 [PubMed - indexed for MEDLINE]
	Change in Liver Function after Selective Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma: JIVROSG-2001 PRESIDENT-ALBI - A Secondary Analysis of a Multicenter Randomized Controlled Trial. Liver Cancer Kodama Y, Ikeda M, Arai Y, Inaba Y, Tanaka T, Arai Y, Sugawara S, Yamazaki H, Aramaki T, Anai H, Morita S, Fujinaga Y, Seki H, Sato M, Kamimura K, Ito J, Tsurusaki M, Nakazawa T, Tokue H, Abo D, Kato K, Hayashi N, Sato O, Sone M. PMID: 41536555 [PubMed - as supplied by publisher]
	Prognosis of liver transplantation and hepatectomy in patients with hepatocellular carcinoma meeting the Milan criteria: A systematic review and meta-analysis. Oncol Lett Wang J, Pan Z, Wang Y, Ye Y, Li W. PMID: 41536546 [PubMed]

Articles 1 - 20 / 58795

Page 1 of 2940



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy